Gene · 53335
Papers3,029
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,029
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Rapid detection of genetic modifiers of β-thalassemia based on MALDI-TOF MS. | Ann Hematol | 2025 | 40016399 | PubTator, text mining | PubMed |
| Phenotype of sickle cell disease. Correlation of haplotypes and polymorphisms in cluster β, BCL11A, and HBS1L-MYB. Pilot study. | Front Med (Lausanne) | 2025 | 40012971 | PubTator, text mining | PubMed |
| Genome-Wide Association Study of Exercise Addiction Among Elite Wrestlers. | Brain Sci | 2025 | 40002435 | PubTator, text mining | PubMed |
| Exploratory Review and In Silico Insights into circRNA and RNA-Binding Protein Roles in γ-Globin to β-Globin Switching. | Cells | 2025 | 39996784 | PubTator, text mining | PubMed |
| Advanced delivery systems for gene editing: A comprehensive review from the GenE-HumDi COST Action Working Group. | Mol Ther Nucleic Acids | 2025 | 39991472 | PubTator, text mining | PubMed |
| Utility of Optical Genome Mapping for Accurate Detection and Fine-Mapping of Structural Variants in Elusive Rare Diseases. | Int J Mol Sci | 2025 | 39941010 | PubTator, text mining | PubMed |
| A replication study of novel fetal hemoglobin-associated genetic variants in sickle cell disease-only cohorts. | Hum Mol Genet | 2025 | 39886999 | PubTator, text mining | PubMed |
| Role of B-Cell Lymphoma/Leukemia 11A in Normal and Malignant Hematopoiesis. | Biology (Basel) | 2025 | 39857257 | PubTator, text mining | PubMed |
| Dias-Logan syndrome with a de novo p.Leu360Profs*212 heterozygous pathogenic variant of BCL11A in a Chinese patient: A case report. | SAGE Open Med Case Rep | 2025 | 39835253 | PubTator, text mining | PubMed |
| Protein-Based Degraders: From Chemical Biology Tools to Neo-Therapeutics. | Chem Rev | 2025 | 39818743 | PubTator, text mining | PubMed |
| The Effect of Single Nucleotide Polymorphisms on Clinical Phenotypes of Sabahan Transfusion-Dependent β-Thalassemia Patients with Homozygous Filipino β0-Deletion. | Hemoglobin | 2025 | 39806862 | PubTator, text mining | PubMed |
| MYB represses ζ-globin expression through upregulating ETO2. | Acta Biochim Biophys Sin (Shanghai) | 2025 | 39757769 | PubTator, text mining | PubMed |
| Direct delivery of Cas-embedded cytosine base editors as ribonucleoprotein complexes for efficient and accurate editing of clinically relevant targets. | Nucleic Acids Res | 2025 | 39676659 | PubTator, text mining | PubMed |
| Redirecting E3 ubiquitin ligases for targeted protein degradation with heterologous recognition domains. | J Biol Chem | 2025 | 39675716 | PubTator, text mining | PubMed |
| Gene editing without ex vivo culture evades genotoxicity in human hematopoietic stem cells. | Cell Stem Cell | 2025 | 39672163 | PubTator, text mining | PubMed |
| The role of miR-129-5p in regulating γ-globin expression and erythropoiesis in β-thalassemia. | Hum Mol Genet | 2025 | 39657657 | PubTator, text mining | PubMed |
| Nonclinical evaluation of HBG1/2 and BCL11A as genome-editing targets for the treatment of β-hemoglobinopathies. | Blood Adv | 2025 | 39637306 | PubTator, text mining | PubMed |
| CD8 + T-Cell-Related Genes: Deciphering Their Role in the Pancreatic Adenocarcinoma TME and Their Effect on Prognosis. | Dig Dis Sci | 2025 | 39604668 | PubTator, text mining | PubMed |
| Gastroesophageal reflux disease increases predisposition to severe COVID-19: Insights from integrated Mendelian randomization and genetic analysis. | Ann Hum Genet | 2025 | 39530352 | PubTator, text mining | PubMed |
| Upregulation of miR‑6747‑3p affects red blood cell lineage development and induces fetal hemoglobin expression by targeting BCL11A in β‑thalassemia. | Mol Med Rep | 2025 | 39450557 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/53335/papers?page=8